Maria R. Granholm

Representative Matters

• Represented IQVIA Inc. (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, in connection with its acquisition of a life sciences consulting and communications company.

• Represented Adhezion Biomedical, a privately held U.S. medical adhesives business, in connection with its acquisition by H.B. Fuller Company (NYSE: FUL), the largest pure play adhesives provider in the world.

• Represented IQVIA Inc. (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, in connection with its acquisition of all shares of capital stock of Cronos Clinical Consulting Services Inc., a leading global provider of specialty clinical service solutions with the goal of improving data quality in clinical trials.

• Represented Element Dental (fka Mid-Atlantic Dental), a portfolio company of a fund sponsored by SC Goldman, in connection with its merger with Sonrava Health (fka Western Dental), a portfolio company of a fund sponsored by New Mountain Capital; the merger created a diversified dental support organization (DSO) offering dental services through 572 offices in 20 states.

• Represented New York Home Health Holdings/Honor Health Network, a provider of home healthcare services, in connection with its multimillion-dollar sale by its members to Webster Capital, a financial sponsor.

• Represented Secure Exchange Solutions, a leading health information technology provider, in its sale to Centauri Health Solutions, Inc., a leading provider of technology-enabled analytics and services and a portfolio company of private equity firm ABRY Partners.

• Represented Tissue Analytics, a developer of automated mobile wound and skin imaging and predictive analytics solutions, in its sale to Net Health, a provider of cloud-based Electronic Health Record (EHR) software for specialized care settings and a portfolio company of The Carlyle Group, Level Equity and Silversmith Capital Partners.

• Represented Psyadon Pharmaceuticals, Inc. in its acquisition by a subsidiary of Paragon Biosciences, bringing with it rights to develop, register and market ecopipam, a new chemical entity with orphan drug designation for the treatment of pediatric Tourette Syndrome.

• Represented Texas Hospice Holdings, LLC, a multi-state hospice facility operator, in connection with the sale of all of its outstanding equity to Amedisys Inc., a publicly-held hospice company.

• Represented Vonage Holding Corp. in its acquisition of certain assets of Over.ai, a Tel Aviv-based Voice Artificial Intelligence provider for enterprise communications. Vonage acquired Over.ai's technical team and intellectual property from i.am+, an AI technology platform co-founded and co-owned by musician will.i.am, thereby gaining significant technology talent and expertise in conversational-related AI.

• Represented an affiliate of Bracket, a leading clinical trial technology and specialty services provider, in its acquisition of mProve Health, a leading provider of mobile technologies for life science companies.

• Represented Red Lion Hotel Corporation in its acquisition of the global hotel brands owned by Vantage Hospitality Group, Inc. for an initial aggregate price of approximately $23 million in cash and 690,000 shares of the Company’s common stock, with the potential for up to an additional $7 million in cash and an additional 690,000 shares to be earned contingent upon the achievement of certain performance metrics.

• Represented a provider of pharmacy services for skilled nursing facilities, and its operating subsidiaries, in connection with the sale of an interest in the subsidiaries to a Boston-based private equity firm, as well as a recapitalization of the subsidiaries involving senior debt and subordinated debt.

• Primary corporate attorney on a team representing Kaiserman Company, Inc. in the sale of controlling interests in, and the recapitalization of, real estate partnerships owning five commercial properties, including The Bourse, with 700,000 square feet in Philadelphia adjacent to Independence National Historic Park.

• Represented Polder Housewares and its affiliates in the sale of substantially all of their assets to a buyer which is majority owned by entities affiliated with Topspin Partners, a suburban New York-based private equity fund.

• Represented Vonage Holdings Corp. in its acquisition of gUnify, Inc., a cloud-based technology company whose middleware solution integrates the Company's cloud communications platform with widely used SaaS business applications, including Google for Work, Zendesk, Salesforce's Sales Cloud, Clio, and other CRM solutions.

• Represented POSC Holdings, LLC, a subsidiary of Argosy Private Equity, in its acquisition of Eagle Automation Limited, a leading oilfield automation company offering services complimentary to Panhandle Oilfield Services Company, Inc., an integrated oilfield services company and portfolio company of Argosy Private Equity.

• Represented Ludwig Bohler in the sale of his interests in Bohler Engineering, P.C. and a series of affiliated entities to employees who collectively owned most of the interests in the acquired entities not previously owned directly or indirectly by Mr. Bohler.

• Represented Sancoa International Company and TubeDec, LLC, family owned affiliated companies that manufacture and supply products to Home & Personal Care customers in North America, in their $71 million sale to CCL Industries, a Canadian public company.

• Represented Brace Industrial Group L.P., a Houston-based industrial services roll-up, in its acquisition of Basic Industries, LLC, an industrial services company, for approximately $33 million.

• Represented a private equity firm in its acquisition of a controlling interest in a manufacturer and distributor of women's and children's socks and indoor footwear.

• Represented Guardian Capital Partners in the acquisition of a controlling interest in Kwik Tek Inc. for an undisclosed sum.

• Represented Pennsylvania dermatology company in raising over $20 million from investors, including prominent venture capital firms, through a preferred stock offering.

• Represented public company in obtaining a no-action letter from the U.S. Securities and Exchange Commission with respect to the exclusion of an improper stockholder proposal from the company's annual proxy materials.

Admissions

• Pennsylvania
• New Jersey

Education

• Villanova University Charles Widger School of Law, J.D., magna cum laude, 2011
  - Associate Editor, Villanova Law Review
  - Order of the Coif
  - Awarded the American Bankruptcy Institute Medal of Excellence
• Eastern University, B.A., summa cum laude, 2007
  - Member of Phi Alpha Theta History Honors Society

Experience

• Duane Morris LLP
  - Special Counsel, 2021-present
  - Associate, 2011-2021

Honors and Awards

• Named to Best Lawyers "Ones to Watch," 2024

Selected Publications

• Co-author, "Insurance Holding Company Act Amendments of 2012," The Legal Intelligencer, July 18, 2012
• Co-author, "SEC Amends Accredited Investor Net Worth Standards per Dodd-Frank," Duane Morris Alert, December 28, 2011

Media Hits

• Quoted, "M&A Legal Fees: 3 Areas That Rack up Costs and How to Keep Fees Low," SimpleLegal, September 30, 2021